Categories
Nevin Manimala Statistics

Primary outcomes by 1q21+ status for isatuximab-treated patients with relapsed/refractory multiple myeloma: Subgroup analyses from ICARIA-MM and IKEMA

Haematologica. 2022 Jun 23. doi: 10.3324/haematol.2022.280660. Online ahead of print.

ABSTRACT

Not available.

PMID:35734925 | DOI:10.3324/haematol.2022.280660

By Nevin Manimala

Portfolio Website for Nevin Manimala